---
search:
  boost: 2 
---

# Antihistamines â€“ Second Generation

This is a subcategory of Respiratory Agents.

## Formulary

### Preferred

| Preferred                               | Generic Name                           | Quantity | Time (Days) |
| :-------------------------------------- | :------------------------------------- | :------: | :---------: |
| Cetirizine Syr <sup>QL</sup>            |                                        |          |             |
| Cetirizine Tab <sup>QL</sup>            | Cetirizine HCI Tabs (all strengths)    |   102    |     102     |
| Cetirizine / Pseudoephedrine            |                                        |          |             |
| Loratadine Rapid Dissolve <sup>QL</sup> | Loratadine Rapidly ODT (all strengths) |   102    |     102     |
| Loratadine Syr <sup>QL</sup>            | Loratadine Syrup (all strengths)       |   1020   |     102     |
| Loratadine Tab <sup>QL</sup>            | Loratadine Tab (all strengths)         |   102    |     102     |
| Loratadine / Pseudoephedrine            |                                        |          |             |

### Non-Preferred

| Non-Preferred                     | Generic Name | Quantity | Time (Days) |
| :-------------------------------- | :----------- | :------: | :---------: |
| Cetirizine Chewable <sup>AR</sup> |              |          |             |
| Clarinex-D                        |              |          |             |
| Desloratadine                     |              |          |             |
| Fexofenadine                      |              |          |             |
| Levocetirizine                    |              |          |             |

## Length of Authorizations

365 Days

## All Authorizations

Must be prescribed in accordance with FDA approved labeling

## Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **30 days** with at least **two different preferred** drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

**AR** - Cetirizine Chewables: a PA is required for patients 6 years and older

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=91)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=30)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
